EGFR and glioblastoma: In the present study, we found that nearly all Classical samples, including glioblastomas and anaplastic gliomas, harbored EGFR amplifications; also, Classical anaplastic gliomas had similar clinical outcomes to their glioblastoma counterparts and therefore should be treated more aggressively.